课题基金 / 基金详情

HUMAN DENDRITIC CELLS AND CHEMOKINES TO ENHANCE IMMUNE RESPONSE TO CANCER

HUMAN DENDRITIC CELLS AND CHEMOKINES TO ENHANCE IMMUNE RESPONSE TO CANCER
人类树突细胞和趋化因子增强癌症的免疫反应
批准号：
6113417
负责人：
JAMES J. MULE
金额：
$0.02万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6113417
关键词：
chemokine clinical research colorectal neoplasms combination cancer therapy dendritic cells human subject human therapy evaluation melanoma neoplasm /cancer immunology neoplasm /cancer immunotherapy transfection

项目摘要

项目成果

JAMES J. MULE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this project application is to bring together adoptive immunotherapy, gene transfer, dendritic cell (DC) isolation and use, and chemokine biology to develop and implement a novel vaccine strategy to ultimately treat patients with solid tumors through the combined use of autologous tumor-pulsed DC and chemokine-secreting gene modified fibroblasts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Development Program
Designing Lymph Nodes for Cancer Immunotherapy
Designing Lymph Nodes for Cancer Immunotherapy
Designing Lymph Nodes for Cancer Immunotherapy
海外基金